Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis have?
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis has 21 citations in the OpenAlex counts ScholarIQ stores.
When was Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis published?
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis has 2018 year in the ScholarIQ index.
What is the open-access status of Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis?
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis has closed oa status in the ScholarIQ index.
What is the DOI of Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis?
The DOI for Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis is on the source record.
What is the PMID of Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis?
The PMID for Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis is on the source record.
What is the OpenAlex record for Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis?
The OpenAlex for Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis is on the source record.